the phosphorylation potential determination and uses in disease

20
The Phosphorylation Potential Determination and Uses in Disease Richard L Veech, MD DPhil Lab of Metabolic Control, NIH

Upload: una

Post on 25-Feb-2016

37 views

Category:

Documents


0 download

DESCRIPTION

The Phosphorylation Potential Determination and Uses in Disease. Richard L Veech, MD DPhil Lab of Metabolic Control, NIH. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: The Phosphorylation Potential Determination and Uses in Disease

The Phosphorylation PotentialDetermination and Uses in Disease

Richard L Veech, MD DPhilLab of Metabolic Control, NIH

Page 2: The Phosphorylation Potential Determination and Uses in Disease

In 1968 Krebs and Veech Proposed The Ratio of ATP/ADPxPi is Related to the Both the Cytosolic and Mitochondrial Redox States Through the GAPDH+ 3PGK Reaction and Electron Transport

The Energy Level and Metabolic Control in Mitochondria, Krebs, HA , Veech RLPp 329-382, Ed Papa, S. et al, Adriatica Editrice, Bari

Page 3: The Phosphorylation Potential Determination and Uses in Disease

The Relation of the Phosphorylation Potential to the Cytosolic Redox State and The Respiratory Chain was

Proposed in 1968 but It Took 10 and 30 Years to Prove

• In 1968 we did not recognize that changes in free [Mg2+ ]would alter the value of Keq

• The value of free [Mg2+] in cells was not known and had to be determined.

• Next Keq had to be determined as function of [Mg2+]

• Finally the value of the mitochondrial membrane potential had to be determined and related the the DG of ATP hydrolysis and redox state of the chain.

Page 4: The Phosphorylation Potential Determination and Uses in Disease

Free Intracellular [Mg2+] ranges from 0.2 to 1.5 mM and is Reflected by the [Citrate]/[Isocitrate] Ratio

][H][H

][H1][H1][Mg

aCit

bMgHCitbMgCitionicAconi

aIsocit

bMgHIsocitbMgIsocitAconi

aIsoCitAconi

aCitionicAconi

2

KK

KKK

KK

KKK

Page 5: The Phosphorylation Potential Determination and Uses in Disease

1 2 3 4 5 6

pMg

6

6.5

7

7.5

8

pH0

1 106

2106

Keq

The variation of K’GG-(TPI+LDH) with pH and free [Mg2+].

Page 6: The Phosphorylation Potential Determination and Uses in Disease

The Cytosolic Phosphorylation Potential J Biol Chem 1979VeecH, RL, Cornell, N., Lawson, J., Krebs, HA

The ratio of [PCr]/[Cr} and the ratio of [DHAP]x[Lactate]/[3PG]x[Pyruvate]give the same ATP/ADPxPi ratio yielding a DG’ of ATP hydrolysis of -53 to-59 kJ/mol in brain, muscle, liver and red cell .

The creatine kinase and GAPDH + 3PG kinase reastions are in near equilibriumwith the phosphorylation potential.

Free [ADP] is about 20 mmolar with the major of ADP being segregated within the mitochondrial matrix.

Page 7: The Phosphorylation Potential Determination and Uses in Disease

Chance_B_PNAS_1986_83_9458-62_fig4

That the free ADP in Cells was Low was Confirmed by NMR

Page 8: The Phosphorylation Potential Determination and Uses in Disease

The Ratio of Free [CoQ]/[CoQH2] Can Be Calculated from the [fumarate]/[succinate] Ratio

9.171][CoQ][succinate

][CoQH[fumarate] 2 SuccDHK

Bergman C. et al, JPhysChemB 114: 16137, 2010Sato K. et al, FASEB J 9: 651,, 1995

And with that the DG ATP between site I and II

][NADH][fumarate

]][NAD[succinateln)''(Δ 2

-2

NAD/NADHfum/succII-compI mito

RTEEnFG

Page 9: The Phosphorylation Potential Determination and Uses in Disease

NH4+

QQH2

H2O

4H+

3H+

H+

ATP

ADP3-

ATP4-

ATP4-

ADP3-

H2PO4- H2PO4

-

H+

3H+

ATP

ADP

Pi

ADPPi

DG ATP hydrolysis4H+

1/2 O2

2H+

4H+

4H+

4H+

4H+

Fum2-

Succ2-

DHB-

AcAc-

Succ CoA-

AcAc CoA

TCA cycle

Cyt C

Cit3-

H+-Picotransporter

ATP synthase

ATP/ADPexchanger

Cyt aa3

H+

NH3 NH3NH4

+

H+

NAD+

NADH+H+Glut-

KG2-

Em/c

CoQH2-Cyt Creductase

Cytochromeoxidase

NADH DH

Succ DH

Red Ox

2e-

Red

Ox

2e-

2e-

Mitochondrial inner membrane

Mitochondrial area: 32.1 -36.8 % water: 17 -20 % of ICW

Matrix

2e-

G GI* GK* GKI*

201612840

-4-8

EhQ/QH2

DG of Q/QH2-NAD+/NADH mG GI* GK* GKI*-50

-52-54-56-58-60-62

kJ/m

olm

V

-260-270-280-290-300-310

Eh NAD+/NADH mG GI* GK* GKI*

mV

measuredcalculated

VO2

G GI* GK* GKI*

20191817161514

m mol

/min

ICW

EhCyt aa3 Ox/Red

G GI* GK* GKI*

mV

620

600

580

560

540

G GI* GK* GKI*

CytosolicDG of ATP hydrolysis

-50-52-54-56-58-60

kJ/m

ol

G GI GK GKI

Cytosolic pH7.67.47.27.06.86.6

Em/cG GI GK* GKI*-100

-110-120-130-140-150

mV

Mitochondrial pH

G GI* GK* GKI*

7.67.47.27.06.86.6

Cytosolic [ADP] and [Pi]

G GI GK GKI

10

8

6

4

2

0[Pi]c

mm

ol/m

l IC

W

160140120100806040

[AD

P]c nmol/m

l ICW

**

*

In Perfused Heart, Ketone Metabolism Increased DG ATP and Mimicked Insulin

FASEB J 9: 651-8, 1995

Page 10: The Phosphorylation Potential Determination and Uses in Disease

R. Yasuda, et. al. Cell 1998 93(7):1117-24. “F1-ATPase is a highly efficient molecular motor that rotates with discrete 120 degree steps”

Page 11: The Phosphorylation Potential Determination and Uses in Disease

Incidence per Year of Disease Phenotype in US Treatable by Ketones

Substrate Insufficiency• Diabetes types I & II• Alzheimer’s• Heart Failure

US Incidence and Source• 25 mill NIDDK• 5.1 mill Alheimers Org• 1.5 mill Am.Heart

• 1 mill Parkinson Foundation• 0.00035 mill ALS Org

• 30 mill FreeMed• 8.5 mill AHA• 6.4 mill AHA

• 33 mill Free Med• 1.5 mill CDC

Free Radical Toxicity• Parkinson’s disease• ALS

Hypoxia • COPD• MI• StrokeInsulin Resistance• Obesity• Traumatic Head Injury

Page 12: The Phosphorylation Potential Determination and Uses in Disease

IP Injection of Short Chain Fatty Acids to Starved Rats Increases CaMgPPi in Liver Mitochondria

• Injecting 2 ml of 2M salts of short chain fatty acids in starved animals increases vasopressin and increased CaMg PPi to about 4 mmole/g which was NMR invisible. The increase in CaMgPPi was accompanied by a drop in the [ATP]/[ADP][Pi] and the DG’ of ATP.Veech RL et al, AdvExpBiolMed 1986, 194: 617-46

• The metabolism of acetate in rat brain decreases the DG’ of ATP in rat brain Pawlosky, R. et al, AlcClinExpRes 2010, 34: 1-7

• The metabolism of D--hydroxybutyrate in rat brain increases the DG’ of ATP. Kashiwaya Y. et al, JBiolChem 2010, 285: 25950-6.

Page 13: The Phosphorylation Potential Determination and Uses in Disease

Traumatic Brain Injury Afflicates 1.5 million Americans per Year and Accounts for 20% of Troop Casualties

• Brain Damage in Traumatic brain injury can be Limited by administration of Cyclosporin which closes the mitochondrial permiability transition pore. Buki A. J Neurotrauma 1999, 16: 511-21Crompton, M. Biochem J. 1999, 341: (pt 2) 233-49

• But cyclosporin A also causes impaired immune function, limiting its therapeutic use.

Page 14: The Phosphorylation Potential Determination and Uses in Disease

Traumatic Brain Injury is Associated with A Low Brain DG of ATP

• TBI is associated with a decrease in brain O2 consumption, increased brain [Lactate]/[pyruvate] and increase brain [creatine], all indicative of a decrease in DG ATP Casey, PA et al, J Neurotrauma 2008, 25: 603-14

• TBI is associated with a decrease in pyruvate dehydrogenase activity Sharma, P, J Emerg Trauma Shock, 2009, 2:67-72

Page 15: The Phosphorylation Potential Determination and Uses in Disease

Ketogenic Diets Can Treat TBI and Increase DG of ATP

• A ketogenic diet limits brain damage after TBIPrins, ML. J CerebBldFlowMetab 2008 28:1-16

• Metabolism of ketone bodies can by pass the block in PDH and increase DG of ATPSato K. FASEB J 1995 9:651-8

Page 16: The Phosphorylation Potential Determination and Uses in Disease

Glucose Glucose

Glycolysis

Pyruvate

PDH

Acetyl CoA

Krebs Cycle

EnergyKetone Body increasesDG ATP

MonocarboxyrateTransporter 1,2,4

MonocarboxyrateTransporter

1,2,4

MonocarboxyrateTransporter(MCT) 1,2,4 Insulin

Resistance

Lactate

NADNADH+

HB HB

Acetoacetate

Acetoacetyl CoA

Succinyl CoA

Succinate

Page 17: The Phosphorylation Potential Determination and Uses in Disease

There are no good tools to diagnoses concussion or TBI

• A CAT scan can diagnose intracranial bleeding after TBI, but give no signal for neuronal injury.

• MRI gives no diagnostic signal in TBI• MRS shows a decrease in PCr in TBI but is not

applicable to field conditions.

Page 18: The Phosphorylation Potential Determination and Uses in Disease

The stopped-flow method and chemical intermediates in enzymereactions – a personal essayBritton ChancePhotosynthesis Research 80: 387–400, 2004.Fig9

Page 19: The Phosphorylation Potential Determination and Uses in Disease

Fig. 3A. Illustration of a merging of the hemoglobin and water absorption spectra to an arbitrary scale to show their spectral overlap and the optimal “windows for minimal crosstalk of the three metrics to be studied.Fig. 3B. Sensitivity of water absorption spectrum to temperature. Thermal difference spectra of water in a 1 mm path length, baseline 37o with lowering to 17 o and rising to 50 o, showing that 970 nm is an appropriate measuring wavelength and 1010 nm is a suitable reference wavelength. A signal increment of 0.010 optical density per degree for a 1 cm optical path is calculated

.

Chance proposed that opening of the mPTP might be visible by NIR providing a diagnotic toolto diagnoses TBI and evaluate treatment

Page 20: The Phosphorylation Potential Determination and Uses in Disease

The stopped-flow method and chemical intermediates in enzymereactions – a personal essayBritton ChancePhotosynthesis Research 80: 387–400, 2004.Fig9